Skip to main content

Table 3 Other secondary & exploratory outcome measures

From: Cortical priming strategies for gait training after stroke: a controlled, stratified trial

Secondary outcomes

Group

Pre

Post

3 M

∆ Pre to Post

∆ Pre to 3 M

6mWT (m)

Control (n = 20)

280 (84)

305 (81)

308 (83)

25 (49)

29 (42)

AMT (n = 20)

274 (84)

308 (91)

297 (90)

34 (37)

22 (37)

tDCS (n = 21)

260 (91)

268 (89)

257 (97)

9 (26)

−2 (27)

tDCS+AMT (n = 20)

307 (87)

329 (87)

319 (94)

22 (37)

13 (44)

BBT

Control (n = 20)

47.8 (4.3)

49.9 (4.3)

50.4 (5.0)

2.2 (3.7)

2.7 (4.7)

AMT (n = 20)

49.7 (5.1)

50.0 (4.4)

50.4 (4.0)

0.4 (3.8)

0.8 (3.5)

tDCS (n = 21)

48.9 (4.6)

50.0 (5.0)

49.7 (4.8)

1.2 (3.0)

0.8 (3.2)

tDCS+AMT (n = 20)

49.1 (5.3)

50.4 (4.0)

50.3 (3.7)

1.4 (3.7)

1.4 (3.7)

SIS-16

Control (n = 20)

212 (53)

228 (52)

229 (64)

16 (24)

18 (43)

AMT (n = 20)

192 (47)

194 (44)

200 (42)

1 (35)

7 (39)

tDCS (n = 21)

177 (34)

190 (38)

182 (34)

22 (42)

5 (46)

tDCS+AMT (n = 20)

209 (32)

222 (38)

219 (38)

13 (26)

10 (18)

Exploratory outcomes

      

TUG (s)

Control (n = 20)

14.1 (4.9)

13.4 (5.0)

13.9 (5.0)

−0.7 (1.9)

−0.3 (1.8)

AMT (n = 20)

14.9 (3.3)

13.9 (3.3)

14.2 (4.1)

−1.0 (1.7)

−0.7 (2.8)

tDCS (n = 21)

17.3 (7.0)

16.2 (7.0)

16.8 (7.5)

−1.1 (2.8)

−0.6 (2.3)

tDCS+AMT (n = 20)

14.6 (5.5)

13.4 (5.1)

15.2 (7.1)

−1.1 (1.9)

0.5 (2.7)

miniBESTest

Control (n = 20)

18.3 (4.7)

20.0 (4.5)

19.0 (4.5)

1.7 (3.7)

0.8 (3.8)

AMT (n = 20)

18.5 (3.9)

19.7 (4.3)

19.8 (4.2)

1.3 (2.7)

1.4 (2.4)

tDCS (n = 21)

17.2 (4.7)

18.6 (4.9)

17.7 (4.4)

1.3 (2.7)

0.5 (2.8)

tDCS+AMT (n = 20)

19.4 (3.9)

20.0 (3.9)

20.5 (4.0)

0.7 (3.1)

1.1 (2.8)

FMLE

Control (n = 20)

21.1 (5.1)

21.6 (5.7)

22.4 (5.5)

0.5 (4.0)

1.3 (3.5)

AMT (n = 20)

21.4 (3.3)

21.7 (4.7)

22.4 (4.4)

0.2 (3.6)

1.1 (2.7)

tDCS (n = 21)

20.0 (4.7)

20.2 (3.8)

20.6 (4.1)

0.1 (3.0)

0.7 (3.1)

tDCS+AMT (n = 20)

22.0 (4.0)

22.3 (3.8)

24.0 (3.9)

0.3 (3.0)

2.1 (4.1)

ABC

Control (n = 20)

73 (16)

74 (15)

76 (18)

1 (13)

2 (17)

AMT (n = 20)

71 (18)

73 (13)

75 (14)

1 (14)

4 (12)

tDCS (n = 21)

69 (16)

72 (18)

72 (17)

3 (15)

3 (14)

tDCS+AMT (n = 20)

76 (17)

79 (11)

76 (15)

4 (10)

0 (12)

  1. Secondary outcome measures were 6-min walk test (6mWT), Berg Balance Test (BBT), and Stroke Impact Scale (SIS). Exploratory outcome measures were Timed Up and Go (TUG), Mini Balance Evaluation Systems Test (miniBESTest), Fugl Meyer Assessment of lower extremity motor function (FMLE), and Activities- Specific Balance Confidence Scale (ABC). Scores are shown for the pre-, post-, and 3-month assessments for the control, ankle motor tracking (AMT), transcranial magnetic stimulation (tDCS) and tDCS+AMT groups. SIS scores are transformed to represent the percentage of the highest possible score. The SIS-16 combines scores from the strength, activities of daily living/instrumental activities of daily living (ADL/IADL), mobility, and hand subscales. Values are mean (SD).
Back to article page

Journal of NeuroEngineering and Rehabilitation

ISSN: 1743-0003

Contact us